Trade Report: Today, First Trust Advisors LP Increases Stake in CME Group Inc. (CME)

Today, First Trust Advisors LP Increases Stake in CME Group Inc. (CME)

First Trust Advisors LP increased its position in CME Group Inc. (NASDAQ:CME) by 4.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 182,366 shares of the company’s stock after buying an additional 8,601 shares during the period. First Trust Advisors LP owned approximately 0.05% of CME Group worth $19,061,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC boosted its stake in shares of CME Group by 447.6% in the second quarter. Tower Research Capital LLC TRC now owns 1,621 shares of the company’s stock worth $157,000 after buying an additional 1,325 shares during the period. Warren Averett Asset Management LLC acquired a new stake in shares of CME Group during the third quarter worth $211,000. Concorde Asset Management LLC acquired a new stake in shares of CME Group during the third quarter worth $216,000. Seaward Management Limited Partnership acquired a new stake in shares of CME Group during the third quarter worth $221,000. Finally, Parametrica Management Ltd acquired a new stake in shares of CME Group during the second quarter worth $212,000. 79.09% of the stock is owned by institutional investors.

CME Group Inc. (NASDAQ:CME) opened at 112.84 on Friday. CME Group Inc. has a 52-week low of $81.87 and a 52-week high of $117.80. The company has a market capitalization of $38.29 billion, a P/E ratio of 26.30 and a beta of 0.81. The firm has a 50-day moving average of $106.96 and a 200 day moving average of $102.74.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 27th. The company reported $1.05 EPS for the quarter, beating the consensus estimate of $1.04 by $0.01. CME Group had a net margin of 41.54% and a return on equity of 6.90%. The business earned $842 million during the quarter, compared to analyst estimates of $855.94 million. During the same quarter in the previous year, the business posted $1.02 EPS. The company’s quarterly revenue was down 1.0% compared to the same quarter last year. Equities analysts predict that CME Group Inc. will post $4.35 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Stockholders of record on Friday, December 9th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Wednesday, December 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.13%. CME Group’s dividend payout ratio is currently 55.94%.

A number of equities research analysts have weighed in on CME shares. Royal Bank Of Canada cut their price objective on shares of CME Group from $97.00 to $92.00 and set an “underperform” rating on the stock in a report on Friday, October 28th. Deutsche Bank AG upped their price objective on shares of CME Group from $115.00 to $116.00 and gave the stock a “buy” rating in a report on Wednesday, October 5th. Jefferies Group upped their price objective on shares of CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a report on Wednesday, August 31st. JPMorgan Chase & Co. set a $116.00 price objective on shares of CME Group and gave the stock a “buy” rating in a report on Monday, September 12th. Finally, RBC Capital Markets set a $92.00 price objective on shares of CME Group and gave the stock a “sell” rating in a report on Friday, October 28th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $102.89.

In other news, Director Dennis Suskind sold 1,000 shares of the business’s stock in a transaction dated Thursday, September 1st. The shares were sold at an average price of $109.49, for a total value of $109,490.00. Following the completion of the sale, the director now owns 10,099 shares in the company, valued at approximately $1,105,739.51. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Phupinder Gill sold 30,002 shares of the business’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $110.00, for a total transaction of $3,300,220.00. Following the completion of the sale, the chief executive officer now owns 116,222 shares of the company’s stock, valued at approximately $12,784,420. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by insiders.

CME Group Company Profile

Related posts

Leave a Comment